We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Transport Medium Evaluated for Gut Bacterium

By LabMedica International staff writers
Posted on 30 Jan 2012
An alternative transport medium supplemented with a cyanobacterial extract (CE) has been evaluated for the preservation and viability of Helicobacter pylori strains. More...


The transport medium was free of animal derivatives, and was compared with other media during long-term transportation and the recovery of H. pylori from biopsy samples.

Microbiologists at the Universidad Nacional de San Luis (Argentina), collected four gastric antral biopsy specimens from 134 patients with gastroduodenal disease and were positive H. pylori infection. The transport media were based on an agar soft medium prepared with Mueller–Hinton broth 0.3% agar (MH) and 0.3% of CE (MH-CE). MH 5% fetal calf serum (FCS) was used as the reference medium (MH-FCS). Two gastric biopsy samples were placed into MH-CE or MH-FCS transport media and stored at 4 °C and at room temperature. Another biopsy sample was used for the urease test and polymerase chain reaction (PCR) identification. The remainder of the biopsy specimen was Gram stained. The diagnosis of H. pylori infection was established when two of three diagnostic methods, urease test, Gram or culture) were positive, followed by confirmation with PCR.

The recovery rate of H. pylori at 4 °C was similar among MH-CE and MH-FCS transport media between 24 to 72 hours, whereas a higher recovery was obtained with MH-CE after 96 and 120 hours. Only MH-CE allowed recovery after 120 hours. The H. pylori recovery at room temperature after 96 hour was higher in MH-CE than in MH-FCS. Similar survival rates were observed in biopsy samples conserved in MH-CE and MH-FCS at 4 °C. The recovery after 48 hours at room temperature in MH-CE was higher than MH-FCS and was the only medium allowing recovery after 72 hours. The viability of H. pylori strains stored within agar plugs in transport media and from biopsy specimens was assessed by viable count determinations (colony-forming units) on Mueller–Hinton agar supplemented with 7% horse blood (MHA-B) and direct fluorescence microscopy with the LIVE/DEAD BacLight Bacterial Viability Kit (Invitrogen Corporation, Eugene, OR, USA).

The authors concluded that MH-CE could be used as a transport medium to minimize the loss of bacterial viability when immediate culture or cool shipping is not possible. The transport medium proposed is simple to handle, inexpensive and complies with the present tendency of avoiding the use of animal derivatives. The study was published in the February 2012 edition of the European Journal of Clinical Microbiology and Infectious Diseases.

Related Links:
Universidad Nacional de San Luis
Invitrogen Corporation


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Biochemical Analyzer
iBC 900
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.